Sep 7, 2023
|
Ardelyx, Inc. Reports Employment Inducement Grants
|
Aug 2, 2023
|
Ardelyx Reports Second Quarter 2023 Financial Results and Provides 2023 IBSRELA Net Sales Revenue Guidance
|
Jul 27, 2023
|
Ardelyx, Inc. Reports Employment Inducement Grants
|
Jul 26, 2023
|
Ardelyx to Report Second Quarter 2023 Financial Results on August 2, 2023
|
Jul 20, 2023
|
Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference
|
Jul 13, 2023
|
Ardelyx Announces Acceptance of New Drug Application for Tenapanor for Hyperphosphatemia in China
|
Jun 29, 2023
|
Ardelyx, Inc. Reports Employment Inducement Grants
|
Jun 5, 2023
|
Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Ardelyx Stockholders Vote in Favor of Proposed Share Increase
|
May 31, 2023
|
Ardelyx to Present at the Jefferies 2023 Healthcare Conference
|
May 23, 2023
|
Ardelyx, Inc. Reports Employment Inducement Grants
|